Latest: FDA Approves New Biosimilar for Oncology Treatment
Pharmaceutical

AlzeCure presents phase 2 data on ACD440 at NeuPSIG 2025

by PharmaTimes
0 Comments
0 Mins
Topical TRPV1 antagonist shows promise in heat-induced neuropathic pain Topical TRPV1 antagonist shows promise in heat-induced neuropathic pain
Tags:
PharmaTimes
Author

PharmaTimes

Previous Post
CMS tweaks AHEAD all-payer model for states
Next Post
Centre stage
📢

Advertisement

300x250 Banner

Recent Content

COPD Biologics: Early Treatment Insights

Pulmonology • 2 hours ago

Antihypertensive Medication Guidelines

Cardiology • 4 hours ago

Juvenile Arthritis Care Transition

Rheumatology • 6 hours ago